A new Israeli study indicates that 95 percent of recovered Covid-19 patients do not suffer any irreversible respiratory or cardiac damage, the Times Of Israel reports.
The study of 166 recovered Covid-19 patients, conducted by Jerusalem’s Shaare Zedek Medical Center, found that 94 percent still reported symptoms three months on, notably shortness of breath, though most symptoms disappeared within six months.
The data showed that at three months after recovery, the most prevalent lasting symptom was shortness of breath, found in 57% of the patients.
In addition, 55% of patients reported overall weakness, 25% reported a sustained cough and 18% reported chest pains. Another 11% still complained of a loss of taste and smell, while 8% exhibited neurological symptoms such as dizziness or weakness in the limbs.
The study, which has not yet been peer-reviewed, included patients from ages 18 to 86 in light, moderate and serious condition.
As we reported earlier, on February 24, the vaccination against Covid-19 has started in Vinnytsia. The mobile brigade that consists of two doctors and three nurses got the first dose of CoviShield vaccine.
“At 13:38, we got the first vaccinated person – doctor Lyudmyla Boiko, who is a member of one of 20 mobile brigades that would hold vaccination from Covid-19,” the message said.
